A grim prognosis, a gamble and one patient’s fight to defy cancer
After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...
TMCnet5h
ORYZON announces first patient dosed in an Investigator-initiated Phase I study of iadademstat in myelodysplastic syndrome
Under the direction of Dr. Guru Subramanian Guru Murthy at the Medical College of Wisconsin Cancer Center, the trial ( NCT06502145) will evaluate the safety, tolerability, and recommended Phase II ...
TMCnet4h
SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia
These data are consistent with previous GPS trials. In the Phase 2 study in AML patients in second complete remission, the median overall survival of GPS-treated patients was 21 months versus 5.4 ...
Labroots23h
Precision Oncology Showcase
The Precision Oncology Showcase is a webinar series sponsored by SOPHiA GENETICS, set to redefine how precision oncology is ...
JONATHAN HAROUNOFF: Israel haters reach sickening lows in New York City
Jonathan Harounoff, Israel's spokesman to the United Nations, observes that anti-Israel agitators have taken their cause to "sickening" new lows in New York City.
The Altamont Enterprise22h
Sandra Ann Mary Hunt Hawrylchak
Sandra Ann Mary Hunt Hawrylchak, a mother of five, had a love of discovery evident in her work as a researcher and archivist ...